The impact of the COVID-19 pandemic on oral cancer incidence in British Columbia, Canada

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:1 publications

Grant number: 519115

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2024.0
  • Known Financial Commitments (USD)

    $86,663.52
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    . Yim Ilena S
  • Research Location

    Canada
  • Lead Research Institution

    B.C. Cancer Research Centre (Vancouver)
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Dental visits provide the perfect opportunity to check the mouth for changes including cancer (oral cancer). However, as a result of the COVID-19 pandemic, there have been interruptions to routine dental visits, combined with an increase in oral cancer risk factors, such as the use of tobacco and alcohol. It is important to know if the pandemic as an event has affected the characteristics and number of cases of oral cancer. Oral cancer, if found late, leads to lower chances of survival and increased complications to daily life related to delayed treatment. The goal of our research is to determine whether the COVID-19 pandemic has impacted the cases of oral cancer in British Columbia, Canada. Data on oral cancer will be collected from the BC Cancer Registry, which is a platform that stores information for all new cancers diagnosed in British Columbia. We will be comparing the trend in characteristics and number of cases of oral cancer before and after the pandemic. The proposed project will be able to address the research gap in evaluating the influence of the COVID-19 pandemic on oral cancer trends beyond 2021, specifically in British Columbia. The results of this research will be able to direct screening efforts of health professionals and public health measures to support early prevention, detection, and management of oral cancer. This research can also provide the foundation for assessing future long-term impacts of the COVID-19 pandemic on oral cancer in British Columbia and globally.

Publicationslinked via Europe PMC

Last Updated:15 hours ago

View all publications at Europe PMC

Evidence for the interaction of peroxiredoxin-4 with the store-operated calcium channel activator STIM1 in liver cells.